New imaging modalities and PET CT in head and neck cancers;Nouvelles techniques d'imagerie et place du PET scanner dans les cancers des voies aéro-digestives supérieures

Oncologie

Volumn 7, Issue 4, 2005, Pages 255-266

  Marcy, P Y ^a   Fontana, X ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Cancer of the head and neck; Medical imaging; Medical oncology; Pet scans

Indexed keywords

3' FLUOROTHYMIDINE F 18; BROMODESOXYURIDINE BR 76; CARBON 11; FLUORINE 18; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEAD AND NECK CANCER; HUMAN; IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY;

EID: 22644433284     PISSN: 12923818     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10269-005-0210-4     Document Type: Article

References (57)

1. Aassar OS, Fischbein NJ, Caputo GR, et al. (1999) Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 210: 177-81
2. Anzai Y, Carroll WR, Quint DJ, et al. (1996) Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18] fluoro-D-glucose PET and MR imaging diagnoses. Radiology 200: 135-41
3. Bohuslavizki KH, Klutmann S, Kroger S, et al. (2000) FDG PET detection of unknown primary tumors. J Nucl Med 41: 816-22
4. Bohuslavizki KH, Klutmann S, Sonnemann U, et al. (1999) F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region. Laryngorhinootologie 8: 445-9
5. Brink I, Klenzner T, Krause T, et al. (2002) Lymph node staging in extracranial head and neck cancer with FDG PET-appropriate uptake period and size-dependence of the results. Nuklearmedizin 2: 108-13
6. Brouwer J, de Bree R, Comans EF, et al. (2004) Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol 9: 479-83
7. Brun E, Kjellen E, Tennvall J, et al. (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2: 127-35
8. Bruschini P, Giorgetti A, Bruschini L, et al. (2003) Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT. Acta Otorhinolaryngol Ital 6: 446-53
9. Chisin R (1999) Nuclear medicine in Head and Neck oncology: reality and perspectives. J Nucl Med 40: 91-5
10. Goerres GW, Schmid DT, Gratz KW, et al. (2003) Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol 6: 547-51
11. Greven KM, Keyes JW Jr, Williams DW 3rd, et al. (1999) Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2 [F-18] luoro-2-deoxy-D-glucose. Cancer 86: 114-8
12. Haenggeli CA, Dulguerov P, Slosman D, et al. (2000) Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma Schweiz Med Wochenschr (Suppl) 116: 8S-11S
13. Haubner RH, Wester HJ, Weber WA, et al. (2003) Radiotracer-based strategies to image angiogenesis. J Nucl Med 47 (3): 189-99
14. Hautzel H, Muller-Gartner HW (1997) Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 38: 1384-6
15. Hyde NC, Prvulovich E, Newman L, et al. (2003) A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 4: 350-60
16. Johansen J, Eigtved A, Buchwald C, et al. (2002) Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 11: 2009-14
17. Keyes JW Jr, Chen MY, Watson NE Jr, et al. (2000) FDG PET evaluation of head and neck cancer: value of imaging the thorax. Head Neck 22: 105-10
18. Keyes JW Jr, Watson NE Jr, Williams DW 3rd, et al. (1997) FDG PET in head and neck cancer. Am J Roentgenol 169: 1663-9
19. Kim HJ, J. Boyd J, Dunphy F, et al. (1998) 18 FDG PET scan after radiotherapy for early-stage larynx cancer. Clin Nucl Med 23: 750-2
20. Kitagawa Y, Sadato N, Azuma H, et al. (1999) FDG PET to evaluate combined intraarterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 40: 1132-7
21. Kitagawa Y, Sano K, Nishizawa S, et al. (2002) FDG-PET for prediction of tumour aggressiveness and response to intraarterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 1: 63-71
22. Kunkel M, Kuffner HD, Reichert TE, et al. (2000) (18F)-2- fluorodeoxyglucose PET. Prospects for secondary prevention of mouth cavity carcinoma. Mund Kiefer Gesichtschir 2: 105-10
23. Laking GR, Price PM (2003) Positron emission tomographic imaging of angiogenesis and vascular function. Br J Radiol 76 (1): S50-9
24. Liu SH, Chang JT, Ng SH (2004) False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient. Br J Radiol 915: 257-60
25. Lowe VJ, Dunphy FR, Varvares M, et al. (1997) Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 19: 666-74
26. McGuirt WF, Greven K, Williams D 3rd, et al. (1998) PET scanning in head and neck oncology: a review. Head Neck 20: 208-15
27. Mendenhall WM, Mancuso AA, Parsons JT, et al. (1998) Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 20: 739-44
28. Miles KA (2003) Functional CT imaging in oncology. Eur Radiol 13 (5): M134-8
29. Minn H, Lapela M, Klemi PJ, et al. (1997) Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38 (12): 1907-11
30. Mukherji SK (1998) Head and Neck imaging: the next 10 years. Radiology 209: 8-14
31. Nagata H, Arai T, Soejima Y, et al. (2004) Limited capability of regional lymph nodes to eradicate metastatic cancer cells. Cancer Res 64 (22): 8239-48
32. Nuutinen J, Jyrkkio S, Lehikoinen P, et al. (1999) Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. Radiother Oncol 52: 225-32
33. Oehr P, Ruhlmann J, Biersack HJ (1999) FDG-PET in clinical oncology: review of the literature and report of one institution's experience. J Investig Med 47: 452-61
34. Padhani AR (2003) MRI for assessing antivascular cancer treatments. Br J Radiol 76: S60-80
35. Pauwels EK, Sturm EJ, Bombardieri E, et al. (2000) Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 126: 549-59
36. Perlow A, Bui C, Shreve P, et al. (2004) High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestivetract. J Comput Assist Tomogr 5: 704-9
37. Porceddu SV, Jarmolowski E, Hicks RJ, et al. (2005) Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer. Head Neck 3: 175-81
38. Rain JD (1999) Intérêt du 18 fluorodéoxyglucose (18FDG) et de la tomographie par émission de positons (TEP) en cancérologie. La Lettre du Cancérologue 8: 44-6
39. Reisser C, Haberkorn U, Dimitrakopoulou-Strauss A, et al. (1995) Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol Head Neck Surg 121: 272-6
40. Righi PD, Kopecky KK, Caldemeyer KS, et al. (1997) Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 19 (7): 604-10
41. Safa AA, Tran LM, Rege S, et al. (1999) The role of positron emission tomography in occult primary head and neck cancers. J Cancer from Scientific American 5: 214-8
42. Schmidt M, Schmalenbach M, Jungehulsing M, et al. (2004) 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin 3: 91-101
43. Schmid DT, Stoeckli SJ, Bandhauer F, et al. (2003) Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 5: 888-91
44. Schwartz DL, Ford E, Rajendran J, et al. (2005) FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1: 129-36
45. Sheikholeslam-Zadeh R, Choufani G, Goldman S, et al. (2002) Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers. Acta Otorhinolaryngol Belg 1: 77-82
46. Sigal R, Vogl T, Casselman J, et al. (2002) Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol 12 (5): 1104-13
47. Sigg MB, Steinert H, Gratz K, et al. (2003) Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities. J Oral Maxillofac Surg 9: 1022-9
48. Stoeckli SJ, Steinert H, Pfaltz M, et al. (2002) Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 4: 345-9
49. Stokkel MP, ten Broek FW, Hordijk GJ, et al. (2000) Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg 2: 229-34
50. Stuckensen T, Kovacs AF, Adams S, et al. (2000) Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 6: 319-24
51. Taraboletti G, Giavazzi R (2004) Modelling approaches for angiogenesis. Eur J Cancer 40 (6): 881-9
52. Terhaard CH, Bongers V, van Rijk PP, et al. (2001) F-18-fluoro-deoxy- glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 11: 933-41
53. Van Den Brekel MWM, Castelijns JA, Stel HV, et al. (1991) Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 180: 457-61
54. Ware RE, Matthews JP, Hicks RJ, et al. (2004) Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck. Head Neck 12: 1008-17
55. Wax MK, Myers LL, Gabalski EC, et al. (2002) Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg 6: 703-7
56. Wong RJ, Lin DT, Schoder H, et al. (2002) Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20: 4199-208
57. Yao M, Graham MM, Hoffman HT, et al. (2004) The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 4: 1001-10